1. Analgesic use during pregnancy and risk of infant leukaemia: a Children's Oncology Group study.
- Author
-
Ognjanovic, S., Blair, C., Spector, L. G., Robison, L. L., Roesler, M., and Ross, J. A.
- Subjects
ANALGESICS ,BLOOD diseases in pregnancy ,ACUTE myeloid leukemia ,NONSTEROIDAL anti-inflammatory agents ,STATISTICAL significance ,ACETAMINOPHEN ,LOGISTIC regression analysis ,DISEASE risk factors ,ASPIRIN ,CLINICAL trials ,COMPARATIVE studies ,LEUKEMIA ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,RESEARCH funding ,EVALUATION research ,PRENATAL exposure delayed effects - Abstract
Background: Infant leukaemia is likely initiated in utero.Methods: We examined whether analgesic use during pregnancy was associated with risk by completing telephone interviews of the mothers of 441 infant leukaemia cases and 323 frequency-matched controls, using unconditional logistic regression.Results: With the exception of a reduced risk for infant acute myeloid leukaemias with non-aspirin non-steroidal anti-inflammatory drugs (NSAID) use early in pregnancy (odds ratios=0.60; confidence intervals: 0.37-0.97), no statistically significant associations were observed for aspirin, non-aspirin NSAIDs, or acetaminophen use in early pregnancy or after knowledge of pregnancy.Conclusion: Overall, analgesic use during pregnancy was not significantly associated with the risk of infant leukaemia. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF